UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acute Myeloid Leukemia

1st ed. 2021., 2021

Volltextzugriff (PDF)

Improving long-term outcomes with intensive induction chemotherapy for patients with AML

Hematology, 2023-12, Vol.2023 (1), p.175-185

Röllig, Christoph

2023

Volltextzugriff (PDF)

Long-Term Mixed Chimerism After Ex Vivo / In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms

Frontiers in oncology, 2021-12, Vol.11, p.776946-776946

2021

Volltextzugriff (PDF)

Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence

NPJ digital medicine, 2024-03, Vol.7 (1), p.76-76, Article 76

2024

Volltextzugriff (PDF)

P556: A NEW MULTIPLEX PCR TOOL ENABLES TIMELY IDENTIFICATION OF ACTIONABLE TARGETS FOR MOLECULAR‐GUIDED THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e5284457-n/a

2023

Volltextzugriff (PDF)

Entstehung, Entwicklung und Erfolge des Kompetenznetzes Akute und Chronische Leukämien (KNL)

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2016, Vol.59 (4), p.444-453

2016

Volltextzugriff (PDF)

Neue Entwicklungen in der Therapie der akuten myeloischen Leukämie

Im Fokus Onkologie, 2016-11, Vol.19 (11), p.48-53

Röllig, Christoph

2016

Volltextzugriff (PDF)

Gegen CD38 gerichtete Therapie beim multiplen Myelom

InFo Hämatologie + Onkologie, 2019-12, Vol.22 (12), p.42-43

2019

Volltextzugriff (PDF)

S123: ACUTE MYELOID LEUKEMIA STEM CELL SUBTYPES DEFINED BY MUTATIONS AND DIFFERENTIATION STATE REGULATE APOPTOTIC DEPENDENCY AND CLINICAL RESPONSE TO VENETOCLAX

HemaSphere, 2023-08, Vol.7 (S3), p.e67012e0-n/a

2023

Volltextzugriff (PDF)

P528: CAN MULTIPARAMETRIC FLOW CYTOMETRY OF PERIPHERAL BLOOD CHALLENGE BONE MARROW ANALYSES FOR DETECTION OF MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA?

HemaSphere, 2023-08, Vol.7 (S3), p.e263908f-n/a

2023

Volltextzugriff (PDF)

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries

Blood cancer journal (New York), 2022-07, Vol.12 (7), p.107-107, Article 107

2022

Volltextzugriff (PDF)

Prinzipien der AML-Therapie

InFo Hämatologie + Onkologie, 2019-08, Vol.22 (7-8), p.15-18

2019

Volltextzugriff (PDF)

Management of Pathological Thoracolumbar Vertebral Fractures in Patients With Multiple Myeloma: Multidisciplinary Recommendations

Global spine journal, 2023-04, Vol.13 (1_suppl), p.85S-93S

2023

Volltextzugriff (PDF)

PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH‐RISK MYELODYSPLASTIC SYNDROME: A FIRST‐IN‐CLINIC PHASE 1 STUDY OF GSK3745417

HemaSphere, 2023-08, Vol.7 (S3), p.e451088e-n/a

2023

Volltextzugriff (PDF)

PB1759: RETAINED FUNCTIONAL NORMAL AND/OR PRE‐LEUKEMIC HSCS IN THE BONE MARROW ARE ASSOCIATED TO GOOD PROGNOSIS IN DNMT3AMUTNPM1MUT AML PATIENTS

HemaSphere, 2023-08, Vol.7 (S3), p.e06701e1-n/a

2023

Volltextzugriff (PDF)

Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia

Biomarker research, 2020-06, Vol.8 (1), p.20-20, Article 20

2020

Volltextzugriff (PDF)

Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies

HemaSphere, 2022-11, Vol.6 (11), p.e787-n/a

2022

Volltextzugriff (PDF)

FLT3-Inhibitoren in der Therapie der akuten myeloischen Leukämie

Best practice onkologie, 2018-06, Vol.13 (4), p.182-190

2018

Volltextzugriff (PDF)

Molecular Detection of Minimal Residual Disease Based on NPM1-Real-Time PCR At the Time of Complete Remission Is a Strong Predictor of Disease Free and Overall Survival in AML

Blood, 2011-11, Vol.118 (21), p.1445-1445

2011

Volltextzugriff (PDF)

Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML – Interim Results of the Bridge Trial

Blood, 2012-11, Vol.120 (21), p.2017-2017

2012

Volltextzugriff (PDF)

Reconstitution of IL-17-Producing T Helper Cells After Allogeneic Hematopoietic Cell Transplantation

Blood, 2012-11, Vol.120 (21), p.4167-4167

2012

Volltextzugriff (PDF)

Prevalence and Prognostic Impact of RUNX1 Mutations In Patients with Acute Myeloid Leukemia (AML): A Study In 1649 Patients Registered In the AML96 Protocol of the DSIL/SAL

Blood, 2010-11, Vol.116 (21), p.754-754

2010

Volltextzugriff (PDF)

High Plasma Lysyloxidase Concentration Is Associated with Inferior Outcome and Extramedullary Disease in Patients with Acute Myeloid Leukemia

Blood, 2011-11, Vol.118 (21), p.935-935

2011

Volltextzugriff (PDF)

1 – 25 von 220

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

Englisch
(204)
Deutsch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Acute Myeloid Leukemia

Improving long-term outcomes with intensive induction chemotherapy for patients with AML

Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD

Long-Term Mixed Chimerism After Ex Vivo / In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms

Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence

P556: A NEW MULTIPLEX PCR TOOL ENABLES TIMELY IDENTIFICATION OF ACTIONABLE TARGETS FOR MOLECULAR‐GUIDED THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

Entstehung, Entwicklung und Erfolge des Kompetenznetzes Akute und Chronische Leukämien (KNL)

Neue Entwicklungen in der Therapie der akuten myeloischen Leukämie

Gegen CD38 gerichtete Therapie beim multiplen Myelom

S123: ACUTE MYELOID LEUKEMIA STEM CELL SUBTYPES DEFINED BY MUTATIONS AND DIFFERENTIATION STATE REGULATE APOPTOTIC DEPENDENCY AND CLINICAL RESPONSE TO VENETOCLAX

P528: CAN MULTIPARAMETRIC FLOW CYTOMETRY OF PERIPHERAL BLOOD CHALLENGE BONE MARROW ANALYSES FOR DETECTION OF MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA?

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries

Prinzipien der AML-Therapie

Management of Pathological Thoracolumbar Vertebral Fractures in Patients With Multiple Myeloma: Multidisciplinary Recommendations

PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH‐RISK MYELODYSPLASTIC SYNDROME: A FIRST‐IN‐CLINIC PHASE 1 STUDY OF GSK3745417

PB1759: RETAINED FUNCTIONAL NORMAL AND/OR PRE‐LEUKEMIC HSCS IN THE BONE MARROW ARE ASSOCIATED TO GOOD PROGNOSIS IN DNMT3AMUTNPM1MUT AML PATIENTS

Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia

Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies

FLT3-Inhibitoren in der Therapie der akuten myeloischen Leukämie

Molecular Detection of Minimal Residual Disease Based on NPM1-Real-Time PCR At the Time of Complete Remission Is a Strong Predictor of Disease Free and Overall Survival in AML

Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML – Interim Results of the Bridge Trial

Reconstitution of IL-17-Producing T Helper Cells After Allogeneic Hematopoietic Cell Transplantation

Prevalence and Prognostic Impact of RUNX1 Mutations In Patients with Acute Myeloid Leukemia (AML): A Study In 1649 Patients Registered In the AML96 Protocol of the DSIL/SAL

Safety and Efficacy of a Combination of 5-Azacitidine Followed by Lenalidomide in High-Risk MDS or AML Patients with Del(5q) Cytogenetic Abnormalities – Results of the “AZALE” Trial

High Plasma Lysyloxidase Concentration Is Associated with Inferior Outcome and Extramedullary Disease in Patients with Acute Myeloid Leukemia

Aktive Filter

Suchergebnisse filtern